Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 142

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 142
---
 of 0.75% per annum for Base Rate Loans and 1.75% per annum for Term SOFR Loans.Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ended June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility is determined by reference to the leverage ratio in effect from time to time as set forth in the following table: Leverage RatioApplicable Margin for Term SOFR LoansApplicable Margin for Base Rate LoansCommitment Fee RateGreater than 4.00 to 1.02.25%1.25%0.35%Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.02.00%1.00%0.30%Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.01.75%0.75%0.25%Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.01.50%0.50%0.20%Less than or equal to 2.00 to 1.01.25%0.25%0.15%

30

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The Term Loan B has an initial applicable margin of 1.5% per annum for Base Rate Loans and 2.5% per annum for Term SOFR Loans.Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ended June 30, 2022, the applicable margin for the Term Loan B is determined by reference to the leverage ratio in effect from time to time as set forth in the following table: Leverage RatioApplicable Margin for Term SOFR LoansApplicable Margin for Base Rate LoansGreater than 2.75 to 1.02.50%1.50%Less than 2.75 to 1.02.25%1.25%Principal PaymentsPrincipal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. The Term Loan A amortizes in nineteen consecutive quarterly installments in an amount equal to 2.50% of the original principal amount in each